DEFEND 2: Durable-Response Therapy Evaluation for Early-

Project: Research project

Project Details

Description

DEFEND 2: Durable-Response Therapy Evaluation for Early- or New-Onset Type 1 Diabetes
StatusFinished
Effective start/end date8/1/107/31/13

Funding

  • Tolerx, Inc.